Skip to content

Ayurvedic Management For Diabetic Induced Nephropathy: A Clinical Trial

Clinical Trial To Study The Effect Of Ayurvedic Treatment In The Management Of Diabetic Nephropathy. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067075
Enrollment
30
Registered
2024-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Sponsors

National Institute of Ayurveda, Deemed to be University, Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having any clinical signs and symptoms of chronic kidney disease. 2.Patients with Blood pressure less than 160/100 mm of hg. 3.Patients of Serum creatinine level 1.2 to 6.5mg/dl. 4.Patients of Blood urea level 48 to 180 mg/dl. 5.Patients with Haemoglobin(Hb) greater than 7gm/dl. 6.Patients with HbA1C less than 9%. 7.Patients with GFR level less than 60 ml/min/1.73m² and persistent(present for greater than 3 months).

Exclusion criteria

Exclusion criteria: 1.Patients who are on dialysis treatment from more than 1 month period. 2.Patients who are already operated for renal transplantation. 3.Patients of end stage renal failure. 4.Patients of hepatorenal insufficiency or renal insufficiency due to hemodynamic circulatory disorders and CCF. 5.Female patients having pregnancy, breast feeding or post delivery period. 6.Patients some serious illness like cardiovascular diseases, acute mental disorders, serious acute organic diseases, serious chronic comorbidity, hypo or hyperthyroidism, liver or metabolic disorders etc.

Design outcomes

Primary

MeasureTime frame
Changes in Renal Function TestTimepoint: From baseline value at the end of 8th week

Secondary

MeasureTime frame
1.Changes in Fasting blood sugar levels and HbA1c levels. 2.Changes in Hb level. 3.Changes in Urine output levels. 4.Changes in Symptoms of DN. Timepoint: From baseline value at the end of 8th week

Countries

India

Contacts

Public ContactDr Harish Bhakuni

National Institute of Ayurveda, Deemed to be University, Jaipur

harishbhakuni78@gmail.com7891233108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026